Jump to content
World's Largest Herpes Support Group
Sign in to follow this  
electthedead

New to this scene

Recommended Posts

electthedead

im 27 and just had my first outbreak.... full of questions and concerns and would just like to talk to others with this problem

Share this post


Link to post
Share on other sites
norcallove

Hi. Welcome to this site. There is a lot of great info to the right, a lot of supportive members who understand what you're going through, and you can also go into the chat room. I'm 26 and had my 1st OB at the end of Nov. I have GHVS2. What do you have? You can also private message me if you want. I can try to answer any questions or ease some of your concerns. I am new to all of this, but I have learned so much in the past 5 weeks.

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • The Hive is Thriving!

    • Total Topics
      70,110
    • Total Posts
      473,852
  • Posts

    • raka
      So, it works as both preventative and cure? when can we expect phase 1 trail start?  
    • RNY18
      https://markets.businessinsider.com/news/stocks/x-vax-technology-raises-56-million-in-upsized-series-a-financing-to-advance-lead-herpes-vaccine-program-1028376554 Add ∆gD-2 (delta gD-2) to the list ! "We believe that ∆gD-2 may be more promising than other previous vaccine candidates because it elicits a different type of immune response against HSV-1 and HSV-2 that is more effective in preclinical models at clearing virus and preventing the establishment of latency. In nonclinical models, immunization with ∆gD-2 elicits antibodies that facilitate the killing of infected cells, rapidly clearing the virus and thereby inducing sterilizing immunity," added William Jacobs, PhD, co-Inventor and Professor of Microbiology & Immunology at Albert Einstein College of Medicine."...
    • RNY18
      More X-Vax Info : https://markets.businessinsider.com/news/stocks/x-vax-technology-raises-56-million-in-upsized-series-a-financing-to-advance-lead-herpes-vaccine-program-1028376554 "We believe that ∆gD-2 may be more promising than other previous vaccine candidates because it elicits a different type of immune response against HSV-1 and HSV-2 that is more effective in preclinical models at clearing virus and preventing the establishment of latency. In nonclinical models, immunization with ∆gD-2 elicits antibodies that facilitate the killing of infected cells, rapidly clearing the virus and thereby inducing sterilizing immunity," added William Jacobs, PhD, co-Inventor and Professor of Microbiology & Immunology at Albert Einstein College of Medicine..."
    • RNY18
      They may not cure HSV but it looks like they are taking positive steps against HIV : https://timesofindia.indiatimes.com/life-style/health-fitness/he alth-news/hiv-cure-soon-human-trials-underway-in-china/articleshow/70316379.cms   "Hopefully, the second-phase trial will be completed in the latter half of 2021, and the third-phase clinical trial may start at the end of that year, which will involve thousands of volunteers in a trial to test the effectiveness of the vaccine to protect people against HIV," the researcher added."...  
    • RNY18
      Got this this morning, definitely positive news. Still seems so far off....
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.